Literature DB >> 11072125

Intragastric beta-casomorphin(1-7) attenuates the suppression of fat intake by enterostatin.

C L White1, G A Bray, D A York.   

Abstract

The current experiments were designed to compare the feeding response to enterostatin and beta-casomorphin(1-7) injected intragastrically. Sprague-Dawley rats with a gastric cannula were allowed to chose from high-fat diet (HF) or low-fat diet (LF) in separate jars. Enterostatin injected intragastrically into overnight fasted rats caused a U-shaped dose-dependent reduction in the intake of the HF diet for the first two hours after infusion but had no effect on the LF intake. beta-Casomorphin(1-7) stimulated the intake of the HF diet but had no effect on the LF diet. Finally, beta-casomorphin(1-7) blocked the inhibitory effect of enterostatin on HF intake in fasted rats.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11072125     DOI: 10.1016/s0196-9781(00)00281-3

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  3 in total

1.  ANGT_HUMAN[448-462], an Anorexigenic Peptide Identified Using Plasma Peptidomics.

Authors:  Sayaka Sasaki; Kazuhito Oba; Yoshio Kodera; Makoto Itakura; Masayoshi Shichiri
Journal:  J Endocr Soc       Date:  2022-05-19

Review 2.  Systematic Review of the Gastrointestinal Effects of A1 Compared with A2 β-Casein.

Authors:  Simon Brooke-Taylor; Karen Dwyer; Keith Woodford; Natalya Kost
Journal:  Adv Nutr       Date:  2017-09-15       Impact factor: 8.701

Review 3.  A1- and A2 beta-casein on health-related outcomes: a scoping review of animal studies.

Authors:  Daniela Kuellenberg de Gaudry; Szimonetta Lohner; Karin Bischoff; Christine Schmucker; Simone Hoerrlein; Christine Roeger; Lukas Schwingshackl; Joerg J Meerpohl
Journal:  Eur J Nutr       Date:  2021-06-01       Impact factor: 5.614

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.